| 1 |
Park JH, Lee Y, Choi M, Park E. The Role of Some Vitamins in Respiratory-related Viral Infections: A Narrative Review. Clin Nutr Res 2023;12:77-89. [PMID: 36793782 DOI: 10.7762/cnr.2023.12.1.77] [Reference Citation Analysis]
|
| 2 |
Ashique S, Gupta K, Gupta G, Mishra N, Singh SK, Wadhwa S, Gulati M, Dureja H, Zacconi F, Oliver BG, Paudel KR, Hansbro PM, Chellappan DK, Dua K. Vitamin D-A prominent immunomodulator to prevent COVID-19 infection. Int J Rheum Dis 2023;26:13-30. [PMID: 36308699 DOI: 10.1111/1756-185X.14477] [Reference Citation Analysis]
|
| 3 |
Ludhiadch A, Yadav UP, Munshi A. Currently available COVID-19 management options. Omics Approaches and Technologies in COVID-19 2023. [DOI: 10.1016/b978-0-323-91794-0.00001-9] [Reference Citation Analysis]
|
| 4 |
Borba V, Carrera-bastos P. Interaction between vitamin D deficiency and COVID-19. Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination 2023. [DOI: 10.1016/b978-0-443-18566-3.00025-6] [Reference Citation Analysis]
|
| 5 |
Eken Gedik D, Dost Sürücü G. Covid-19 hastalarında serum 25-OH vitamin D3 düzeyleri ve hastalık aktivitesine etkileri: Prospektif kesitsel bir çalışma. ADYÜ Sağlık Bilimleri Derg 2022. [DOI: 10.30569/adiyamansaglik.1128161] [Reference Citation Analysis]
|
| 6 |
Djordjevic B, Milenkovic J, Stojanovic D, Velickov A, Djindjic B, Jevtovic Stoimenov T. Vitamins, microelements and the immune system: current standpoint in the fight against coronavirus disease 2019. Br J Nutr 2022;128:2131-46. [PMID: 35057876 DOI: 10.1017/S0007114522000083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Karonova TL, Rudenco EV, Radaeva OA, Chernikova AT, Golovatyuk KA, Shlyakhto EV. Vitamin D status during the COVID-19 pandemic: the experience of Russia and Belarus. Vescì Nac akad navuk Belarusì, Ser med navuk 2022;19:424-432. [DOI: 10.29235/1814-6023-2022-19-4-424-432] [Reference Citation Analysis]
|
| 8 |
Estrada-luna D, Carreón-torres E, González-reyes S, Martínez-salazar MF, Ortiz-rodríguez MA, Ramírez-moreno E, Arias-rico J, Jiménez-osorio AS. Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19. Life 2022;12:1652. [DOI: 10.3390/life12101652] [Reference Citation Analysis]
|
| 9 |
Feiner Solís Á, Avedillo Salas A, Luesma Bartolomé MJ, Santander Ballestín S. The Effects of Vitamin D Supplementation in COVID-19 Patients: A Systematic Review. IJMS 2022;23:12424. [DOI: 10.3390/ijms232012424] [Reference Citation Analysis]
|
| 10 |
Sarhan N, Abou Warda AE, Sarhan RM, Boshra MS, Mostafa-hedeab G, Alruwaili BF, Ibrahim HSG, Schaalan MF, Fathy S. Evidence for the Efficacy of a High Dose of Vitamin D on the Hyperinflammation State in Moderate-to-Severe COVID-19 Patients: A Randomized Clinical Trial. Medicina 2022;58:1358. [DOI: 10.3390/medicina58101358] [Reference Citation Analysis]
|
| 11 |
Li B, Yang S, Hou N. Could vitamin D supplementation play a role against COVID-19? Front Immunol 2022;13:967215. [DOI: 10.3389/fimmu.2022.967215] [Reference Citation Analysis]
|
| 12 |
Karampela I, Vallianou N, Magkos F, Apovian CM, Dalamaga M. Obesity, Hypovitaminosis D, and COVID-19: the Bermuda Triangle in Public Health. Curr Obes Rep 2022;11:116-25. [PMID: 35391661 DOI: 10.1007/s13679-022-00471-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 13 |
Cicero AFG, Fogacci F, Borghi C. Vitamin D Supplementation and COVID-19 Outcomes: Mounting Evidence and Fewer Doubts. Nutrients 2022;14:3584. [DOI: 10.3390/nu14173584] [Reference Citation Analysis]
|
| 14 |
Alaraj M, Alenazi FS, Hassan D, Hossain A. Vitamin D as a drug: new therapeutic approaches. PHAR 2022;69:765-770. [DOI: 10.3897/pharmacia.69.e85057] [Reference Citation Analysis]
|
| 15 |
D'Ecclesiis O, Gavioli C, Martinoli C, Raimondi S, Chiocca S, Miccolo C, Bossi P, Cortinovis D, Chiaradonna F, Palorini R, Faciotti F, Bellerba F, Canova S, Jemos C, Salé EO, Gaeta A, Zerbato B, Gnagnarella P, Gandini S. Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis. PLoS One 2022;17:e0268396. [PMID: 35793346 DOI: 10.1371/journal.pone.0268396] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Jude EB, Tentolouris N, Rastogi A, Yap MH, Pedrosa HC, Ling SF. Vitamin D prescribing practices among clinical practitioners during the COVID‐19 pandemic. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.691] [Reference Citation Analysis]
|
| 17 |
Briceno Noriega D, Savelkoul HFJ. Vitamin D: A Potential Mitigation Tool for the Endemic Stage of the COVID-19 Pandemic? Front Public Health 2022;10:888168. [PMID: 35757617 DOI: 10.3389/fpubh.2022.888168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Karonova TL, Golovatyuk KA, Kudryavtsev IV, Chernikova AT, Mikhaylova AA, Aquino AD, Lagutina DI, Zaikova EK, Kalinina OV, Golovkin AS, Grant WB, Shlyakhto EV. Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study. Nutrients 2022;14. [PMID: 35807783 DOI: 10.3390/nu14132602] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 19 |
Chiang W, Hsiao P, Chan J. Vitamin D for Recovery of COVID-19 in Patients With Chronic Kidney Disease. Front Nutr 2022;9:930176. [DOI: 10.3389/fnut.2022.930176] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 20 |
Entrenas-Castillo M, Salinero-González L, Entrenas-Costa LM, Andújar-Espinosa R. Calcifediol for Use in Treatment of Respiratory Disease. Nutrients 2022;14:2447. [PMID: 35745177 DOI: 10.3390/nu14122447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Hosseini B, El Abd A, Ducharme FM. Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis. Nutrients 2022;14:2134. [DOI: 10.3390/nu14102134] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 22 |
Menéndez SG, Martín Giménez VM, Holick MF, Barrantes FJ, Manucha W. COVID-19 and neurological sequelae: Vitamin D as a possible neuroprotective and/or neuroreparative agent. Life Sci 2022;297:120464. [PMID: 35271880 DOI: 10.1016/j.lfs.2022.120464] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 23 |
Aloul KM, Nielsen JE, Defensor EB, Lin JS, Fortkort JA, Shamloo M, Cirillo JD, Gombart AF, Barron AE. Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis. Front Immunol 2022;13:880961. [DOI: 10.3389/fimmu.2022.880961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 24 |
Degarege A, Naveed Z, Kabayundo J, Brett-Major D. Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis. Pathogens 2022;11. [PMID: 35631084 DOI: 10.3390/pathogens11050563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Annweiler C, Beaudenon M, Gautier J, Gonsard J, Boucher S, Chapelet G, Darsonval A, Fougère B, Guérin O, Houvet M, Ménager P, Roubaud-Baudron C, Tchalla A, Souberbielle JC, Riou J, Parot-Schinkel E, Célarier T; COVIT-TRIAL study group. High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial. PLoS Med 2022;19:e1003999. [PMID: 35639792 DOI: 10.1371/journal.pmed.1003999] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 26 |
Piazza M, Di Cicco M, Pecoraro L, Ghezzi M, Peroni D, Comberiati P. Long COVID-19 in Children: From the Pathogenesis to the Biologically Plausible Roots of the Syndrome. Biomolecules 2022;12:556. [DOI: 10.3390/biom12040556] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 27 |
di Filippo L, Doga M, Frara S, Giustina A. Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications. Rev Endocr Metab Disord 2022;23:299-308. [PMID: 33846867 DOI: 10.1007/s11154-021-09655-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 40.0] [Reference Citation Analysis]
|
| 28 |
Bandeira L, Lazaretti-Castro M, Binkley N. Clinical aspects of SARS-CoV-2 infection and vitamin D : COVID-19 and the endocrine system: special issue for reviews in endocrine and metabolic disorders (Felipe Casaneuva, Editor in Chief) A. Giustina and JP Bilezikian, Guest Editors. Rev Endocr Metab Disord 2022;23:287-91. [PMID: 34559361 DOI: 10.1007/s11154-021-09683-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 29 |
Ismailova A, White JH. Vitamin D, infections and immunity. Rev Endocr Metab Disord 2022;23:265-77. [PMID: 34322844 DOI: 10.1007/s11154-021-09679-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 13] [Article Influence: 37.0] [Reference Citation Analysis]
|
| 30 |
Calder PC. Response to Singh and Singh. Nutr Diabetes 2022;12:14. [PMID: 35354786 DOI: 10.1038/s41387-022-00195-2] [Reference Citation Analysis]
|
| 31 |
Albergamo A, Apprato G, Silvagno F. The Role of Vitamin D in Supporting Health in the COVID-19 Era. Int J Mol Sci 2022;23:3621. [PMID: 35408981 DOI: 10.3390/ijms23073621] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 32 |
Walsh JB, Mccartney DM, Laird É, Mccarroll K, Byrne DG, Healy M, O’shea PM, Kenny RA, Faul JL. Title: Understanding a Low Vitamin D State in the Context of COVID-19. Front Pharmacol 2022;13:835480. [DOI: 10.3389/fphar.2022.835480] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 33 |
Holick MF. The CO-VID D-Lemma: A Call for Action. Nutrients 2022;14:963. [DOI: 10.3390/nu14050963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 34 |
Pisoschi AM, Pop A, Iordache F, Stanca L, Geicu OI, Bilteanu L, Serban AI. Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114175] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 35 |
Tsourdi E. Osteoporose-Management während der COVID-19 Pandemie. Osteologie 2022;31:31-37. [DOI: 10.1055/a-1712-4009] [Reference Citation Analysis]
|
| 36 |
Pedrosa LF, Barros AN, Leite-lais L. Nutritional risk of vitamin D, vitamin C, zinc, and selenium deficiency on risk and clinical outcomes of COVID-19: A narrative review. Clinical Nutrition ESPEN 2022;47:9-27. [DOI: 10.1016/j.clnesp.2021.11.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 37 |
Giannini S, Giusti A, Minisola S, Napoli N, Passeri G, Rossini M, Sinigaglia L. The Immunologic Profile of Vitamin D and Its Role in Different Immune-Mediated Diseases: An Expert Opinion. Nutrients 2022;14:473. [PMID: 35276834 DOI: 10.3390/nu14030473] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 38 |
Leal-Martínez F, Abarca-Bernal L, García-Pérez A, González-Tolosa D, Cruz-Cázares G, Montell-García M, Ibarra A. Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial. Int J Environ Res Public Health 2022;19:1172. [PMID: 35162195 DOI: 10.3390/ijerph19031172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 39 |
Chiodini I, Gatti D, Soranna D, Merlotti D, Mingiano C, Fassio A, Adami G, Falchetti A, Eller-Vainicher C, Rossini M, Persani L, Zambon A, Gennari L. Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes. Front Public Health 2021;9:736665. [PMID: 35004568 DOI: 10.3389/fpubh.2021.736665] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 37.0] [Reference Citation Analysis]
|
| 40 |
Golovatyuk K, Karonova T, Mikhailova A, Lagutina D, Chernikova A, Vasilieva E, Shlyakhto E. Cholecalciferol as part of complex therapy for acute COVID-19. Profil med 2022;25:106. [DOI: 10.17116/profmed202225121106] [Reference Citation Analysis]
|
| 41 |
Efird JT, Anderson EJ, Jindal C, Redding TS, Thompson AD, Press AM, Upchurch J, Williams CD, Choi YM, Suzuki A. The Interaction of Vitamin D and Corticosteroids: A Mortality Analysis of 26,508 Veterans Who Tested Positive for SARS-CoV-2. Int J Environ Res Public Health 2021;19:447. [PMID: 35010701 DOI: 10.3390/ijerph19010447] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 42 |
Jandaghi P, Hosseini Z, Chilibeck P, Hanley AJ, Deguire JR, Bandy B, Pahwa P, Vatanparast H. The Role of Immunomodulatory Nutrients in Alleviating Complications Related to SARS-CoV-2: A Scoping Review. Adv Nutr 2021;13:424-38. [PMID: 34932789 DOI: 10.1093/advances/nmab128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 43 |
Putra H, Efrida, Yaswir R. Vitamin D Levels among Hospitalized and Non-Hospitalized COVID-19 Patients in Dr. M. Djamil General Hospital Padang. EJMED 2021;3:78-81. [DOI: 10.24018/ejmed.2021.3.6.1131] [Reference Citation Analysis]
|
| 44 |
Cromer SJ, Yu EW. Challenges and Opportunities for Osteoporosis Care During the COVID-19 Pandemic. J Clin Endocrinol Metab 2021;106:e4795-808. [PMID: 34343287 DOI: 10.1210/clinem/dgab570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 45 |
Ghasemian R, Shamshirian A, Heydari K, Malekan M, Alizadeh-Navaei R, Ebrahimzadeh MA, Ebrahimi Warkiani M, Jafarpour H, Razavi Bazaz S, Rezaei Shahmirzadi A, Khodabandeh M, Seyfari B, Motamedzadeh A, Dadgostar E, Aalinezhad M, Sedaghat M, Razzaghi N, Zarandi B, Asadi A, Yaghoubi Naei V, Beheshti R, Hessami A, Azizi S, Mohseni AR, Shamshirian D. The role of vitamin D in the age of COVID-19: A systematic review and meta-analysis. Int J Clin Pract 2021;75:e14675. [PMID: 34322971 DOI: 10.1111/ijcp.14675] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 23.5] [Reference Citation Analysis]
|
| 46 |
Annweiler C. The COVID-19 era recalls the importance of ensuring sufficient vitamin D status in the general population. J Steroid Biochem Mol Biol 2021;214:105959. [PMID: 34339829 DOI: 10.1016/j.jsbmb.2021.105959] [Reference Citation Analysis]
|
| 47 |
Jude EB, Ling SF, Allcock R, Yeap BXY, Pappachan JM. Vitamin D Deficiency Is Associated With Higher Hospitalization Risk From COVID-19: A Retrospective Case-control Study. J Clin Endocrinol Metab 2021;106:e4708-15. [PMID: 34139758 DOI: 10.1210/clinem/dgab439] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 48 |
Kongsbak-Wismann M, Al-Jaberi FAH, Schmidt JD, Ghanizada M, Hansen CB, Lopez DV, Woetmann A, Ødum N, Bonefeld CM, Stryhn A, Garred P, Buus S, Geisler C. Normal T and B Cell Responses Against SARS-CoV-2 in a Family With a Non-Functional Vitamin D Receptor: A Case Report. Front Immunol 2021;12:758154. [PMID: 34659264 DOI: 10.3389/fimmu.2021.758154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 49 |
Speakman LL, Michienzi SM, Badowski ME. Vitamins, supplements and COVID-19: a review of currently available evidence. Drugs Context 2021;10:2021-6-2. [PMID: 34659426 DOI: 10.7573/dic.2021-6-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 50 |
Karonova TL, Andreeva AT, Golovatyuk KA, Bykova ES, Skibo II, Grineva EN, Shlyakhto EV. [SARS-CoV-2 morbidity depending on vitamin D status]. Probl Endokrinol (Mosk) 2021;67:20-8. [PMID: 34766486 DOI: 10.14341/probl12820] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 51 |
Castle RD, Williams MA, Bushell WC, Rindfleisch JA, Peterson CT, Marzolf J, Brouwer K, Mills PJ. Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and Meditation. J Inflamm Res 2021;14:4859-76. [PMID: 34588793 DOI: 10.2147/JIR.S323356] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 52 |
Ghelani D, Alesi S, Mousa A. Vitamin D and COVID-19: An Overview of Recent Evidence. Int J Mol Sci 2021;22:10559. [PMID: 34638897 DOI: 10.3390/ijms221910559] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 53 |
Nogues X, Ovejero D, Pineda-Moncusí M, Bouillon R, Arenas D, Pascual J, Ribes A, Guerri-Fernandez R, Villar-Garcia J, Rial A, Gimenez-Argente C, Cos ML, Rodriguez-Morera J, Campodarve I, Quesada-Gomez JM, Garcia-Giralt N. Calcifediol Treatment and COVID-19-Related Outcomes. J Clin Endocrinol Metab 2021;106:e4017-27. [PMID: 34097036 DOI: 10.1210/clinem/dgab405] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 54 |
Vasheghani M, Jannati N, Baghaei P, Rezaei M, Aliyari R, Marjani M. The relationship between serum 25-hydroxyvitamin D levels and the severity of COVID-19 disease and its mortality. Sci Rep 2021;11:17594. [PMID: 34475485 DOI: 10.1038/s41598-021-97017-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 55 |
Hou H, Xu J, Li Y, Wang Y, Yang H. The Association of Asthma With COVID-19 Mortality: An Updated Meta-Analysis Based on Adjusted Effect Estimates. J Allergy Clin Immunol Pract 2021;9:3944-3968.e5. [PMID: 34464749 DOI: 10.1016/j.jaip.2021.08.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 56 |
Tomasa-Irriguible TM, Bielsa-Berrocal L, Bordejé-Laguna L, Tural-Llàcher C, Barallat J, Manresa-Domínguez JM, Torán-Monserrat P. Low Levels of Few Micronutrients May Impact COVID-19 Disease Progression: An Observational Study on the First Wave. Metabolites 2021;11:565. [PMID: 34564381 DOI: 10.3390/metabo11090565] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 57 |
Xu J, Xiao W, Liang X, Shi L, Zhang P, Wang Y, Wang Y, Yang H. A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity. BMC Public Health 2021;21:1533. [PMID: 34380456 DOI: 10.1186/s12889-021-11051-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 58 |
Oristrell J, Oliva JC, Casado E, Subirana I, Domínguez D, Toloba A, Balado A, Grau M. Vitamin D supplementation and COVID-19 risk: a population-based, cohort study. J Endocrinol Invest 2021. [PMID: 34273098 DOI: 10.1007/s40618-021-01639-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 59 |
Vassiliou AG, Jahaj E, Orfanos SE, Dimopoulou I, Kotanidou A. Vitamin D in infectious complications in critically ill patients with or without COVID-19. Metabol Open 2021;11:100106. [PMID: 34250458 DOI: 10.1016/j.metop.2021.100106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 60 |
Al Kiyumi MH, Kalra S, Davies JS, Kalhan A. The Impact of Vitamin D Deficiency on the Severity of Symptoms and Mortality Rate among Adult Patients with Covid-19: A Systematic Review and Meta-Analysis. Indian J Endocrinol Metab 2021;25:261-82. [PMID: 35136732 DOI: 10.4103/ijem.ijem_115_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 61 |
Crafa A, Cannarella R, Condorelli RA, Mongioì LM, Barbagallo F, Aversa A, La Vignera S, Calogero AE. Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis. EClinicalMedicine 2021;37:100967. [PMID: 34179737 DOI: 10.1016/j.eclinm.2021.100967] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 62 |
Hariyanto TI, Intan D, Hananto JE, Harapan H, Kurniawan A. Vitamin D supplementation and Covid‐19 outcomes: A systematic review, meta‐analysis and meta‐regression. Rev Med Virol. [DOI: 10.1002/rmv.2269] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 63 |
Pal R, Banerjee M, Bhadada SK, Shetty AJ, Singh B, Vyas A. Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis. J Endocrinol Invest 2021. [PMID: 34165766 DOI: 10.1007/s40618-021-01614-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 42] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 64 |
Calder PC. Nutrition and immunity: lessons for COVID-19. Nutr Diabetes 2021;11:19. [PMID: 34168111 DOI: 10.1038/s41387-021-00165-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 65 |
Bassatne A, Basbous M, Chakhtoura M, El Zein O, Rahme M, El-Hajj Fuleihan G. The link between COVID-19 and VItamin D (VIVID): A systematic review and meta-analysis. Metabolism 2021;119:154753. [PMID: 33774074 DOI: 10.1016/j.metabol.2021.154753] [Cited by in Crossref: 97] [Cited by in F6Publishing: 78] [Article Influence: 48.5] [Reference Citation Analysis]
|
| 66 |
Alcala-Diaz JF, Limia-Perez L, Gomez-Huelgas R, Martin-Escalante MD, Cortes-Rodriguez B, Zambrana-Garcia JL, Entrenas-Castillo M, Perez-Caballero AI, López-Carmona MD, Garcia-Alegria J, Lozano Rodríguez-Mancheño A, Arenas-de Larriva MDS, Pérez-Belmonte LM, Jungreis I, Bouillon R, Quesada-Gomez JM, Lopez-Miranda J. Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study. Nutrients 2021;13:1760. [PMID: 34064175 DOI: 10.3390/nu13061760] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 20.5] [Reference Citation Analysis]
|
| 67 |
Lakkireddy M, Gadiga SG, Malathi RD, Karra ML, Raju ISSVPM, Ragini, Chinapaka S, Baba KSSS, Kandakatla M. Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease. Sci Rep 2021;11:10641. [PMID: 34017029 DOI: 10.1038/s41598-021-90189-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 51] [Article Influence: 21.5] [Reference Citation Analysis]
|
| 68 |
Ponzo V, Pellegrini M, D'Eusebio C, Bioletto F, Goitre I, Buscemi S, Frea S, Ghigo E, Bo S. Mediterranean Diet and SARS-COV-2 Infection: Is There Any Association? A Proof-of-Concept Study. Nutrients 2021;13:1721. [PMID: 34069656 DOI: 10.3390/nu13051721] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 69 |
Peng MY, Liu WC, Zheng JQ, Lu CL, Hou YC, Zheng CM, Song JY, Lu KC, Chao YC. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D. Int J Mol Sci 2021;22:5251. [PMID: 34065735 DOI: 10.3390/ijms22105251] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 70 |
Spolidoro GCI, Azzolino D, Shamir R, Cesari M, Agostoni C. Joint Effort towards Preventing Nutritional Deficiencies at the Extremes of Life during COVID-19. Nutrients 2021;13:1616. [PMID: 34065864 DOI: 10.3390/nu13051616] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 71 |
Lordan R, Rando HM, Greene CS; COVID-19 Review Consortium. Dietary Supplements and Nutraceuticals under Investigation for COVID-19 Prevention and Treatment. mSystems 2021;6:e00122-21. [PMID: 33947804 DOI: 10.1128/mSystems.00122-21] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 72 |
Shah Alam M, Czajkowsky DM, Aminul Islam M, Ataur Rahman M. The role of vitamin D in reducing SARS-CoV-2 infection: An update. Int Immunopharmacol 2021;97:107686. [PMID: 33930705 DOI: 10.1016/j.intimp.2021.107686] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 73 |
Ünal O. COVID-19 Tedavisinde Vitamin C ve D. SDÜ Tıp Fakültesi Dergisi 2021. [DOI: 10.17343/sdutfd.903824] [Reference Citation Analysis]
|
| 74 |
Banerjee A, Ganguly U, Saha S, Chakrabarti S, Saini RV, Rawal RK, Saso L, Chakrabarti S. Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits. Expert Rev Anti Infect Ther 2021;:1-14. [PMID: 33739215 DOI: 10.1080/14787210.2021.1905519] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 75 |
Charoenngam N, Shirvani A, Holick MF. Vitamin D and Its Potential Benefit for the COVID-19 Pandemic. Endocr Pract 2021;27:484-93. [PMID: 33744444 DOI: 10.1016/j.eprac.2021.03.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 76 |
Fond G, Masson M, Richieri R, Korchia T, Etchecopar-Etchart D, Sunhary de Verville PL, Lançon C, Boyer L. The Covid-19 infection: An opportunity to develop systematic vitamin D supplementation in psychiatry. Encephale 2021:S0013-7006(21)00057-9. [PMID: 33820650 DOI: 10.1016/j.encep.2021.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 77 |
Silberstein M. COVID-19 and IL-6: Why vitamin D (probably) helps but tocilizumab might not. Eur J Pharmacol 2021;899:174031. [PMID: 33722593 DOI: 10.1016/j.ejphar.2021.174031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 78 |
Kralj M, Jakovac H. Vitamin D and COVID-19 in an immunocompromised patient with multiple comorbidities-A Case Report. Clin Case Rep 2021. [PMID: 33821193 DOI: 10.1002/ccr3.4010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 79 |
Turrubiates-Hernández FJ, Sánchez-Zuno GA, González-Estevez G, Hernández-Bello J, Macedo-Ojeda G, Muñoz-Valle JF. Potential immunomodulatory effects of vitamin D in the prevention of severe coronavirus disease 2019: An ally for Latin America (Review). Int J Mol Med 2021;47:32. [PMID: 33537824 DOI: 10.3892/ijmm.2021.4865] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 80 |
Lordan R, Rando HM, Greene CS; COVID-19 Review Consortium. Dietary Supplements and Nutraceuticals Under Investigation for COVID-19 Prevention and Treatment. ArXiv 2021:arXiv. [PMID: 33564696] [Reference Citation Analysis]
|
| 81 |
Brenner H. Vitamin D Supplementation to Prevent COVID-19 Infections and Deaths-Accumulating Evidence from Epidemiological and Intervention Studies Calls for Immediate Action. Nutrients 2021;13:411. [PMID: 33525447 DOI: 10.3390/nu13020411] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 82 |
Boretti A. Vitamin D and SARS-CoV-2 Infection. Asian J Org Med Chem 2021;6:68-72. [DOI: 10.14233/ajomc.2021.ajomc-p313] [Reference Citation Analysis]
|
| 83 |
Poulin D. Revue du rôle possible de la vitamine D dans le traitement de la COVID-19 et recommandations pratiques. Nutrition Science en évolution 2021;19:19. [DOI: 10.7202/1084270ar] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 84 |
[DOI: 10.1101/2020.06.05.20123554] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
|
